EUVIMEDSkopri EUVIMED
Crossref

Hepatitis C Virus Antibodies In Nigerians With Hepatocellular Carcinoma

The Internet Journal of Oncology · 2007

DOI: 10.5580/1669 ↗

At a glance

Journal article in The Internet Journal of Oncology, 2007.

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

The aim of the study is to determine the frequency of antibodies to hepatitis C virus among Nigerian patients with hepatocellular carcinoma.

Method

The study was prospective. Patients with histologically confirmed hepatocellular carcinoma were studied. Sera of the patients were tested for hepatitis C virus antibodies using a third generation ELISA.

Results

A total of 108 patients consisting of 81 males and 27 females were studied, giving a male to female ratio of 4:1. Their ages ranged from 22 to 75 years with a mean of 48 years (SD±13.0). The highest incidence of hepatocellular carcinoma was found among those aged 4049 years. A total of 19 patients (17.6%) were positive for HCV antibodies. There was no significant difference in the frequencies of these antibodies between the male and female patients.

Conclusion

HCV plays a significant role in the etiology of hepatocellular carcinoma in Nigeria. Therefore, patients with chronic hepatitis C should be screened for HCC on regular basis.

Cite

APA

(2007). Hepatitis C Virus Antibodies In Nigerians With Hepatocellular Carcinoma. The Internet Journal of Oncology. https://doi.org/10.5580/1669

Vancouver

Hepatitis C Virus Antibodies In Nigerians With Hepatocellular Carcinoma. The Internet Journal of Oncology. 2007. doi:10.5580/1669

BibTeX
@article{euvimed2007,
  title = {Hepatitis C Virus Antibodies In Nigerians With Hepatocellular Carcinoma},
  journal = {The Internet Journal of Oncology},
  year = {2007},
  doi = {10.5580/1669}
}
Start for free →